Sylvan advises clients on developing patent strategies to suit their commercial objectives, with a specific focus on patent protection in the North American, European and Asian markets. In recent years, he has developed a particularly detailed understanding of the IP landscape in Korea and travels there regularly.
Sylvan previously worked with a prominent IP firm in Canada for four years, where he practiced as a patent agent representing clients before the Canadian Intellectual Property Office and the US Patent and Trademark Office. During his time practicing in North America, he gained significant experience drafting and prosecuting US, Canadian and European patents for sophisticated technology companies.
06 Sep 2016
Monoclonal antibodies are important human therapeutic agents and represent some of the largest selling drugs in the world. Patents relating to antibodies are treated differently to some other compounds in some jurisdictions. This article touches on some of the important requirements for antibody patenting in some major Asian jurisdictions, namely Japan, China and South Korea.
08 Jul 2014
A bill to revise the Korean Patent Act was passed in the Korean Congress on 29 April 2014. This is a summary of the revisions, which will come in to effect on 1 January 2015.